Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I have to unfortunately agree with you samalone. Your last post about dilution was very pertinent. This company has trapped itself into a tight spot now. If the share price doesn't go up dramatically with the lab opening, it will prove to me there's little confidence from investors. I just hope I can get out ahead and before the R/S.
But seriously, one would think that with the prospects of this company opening up its own lab and all the PR that went along with it, the stock price would be higher. The last PR had zero impact on investors considering that the after effects of the last 10-Q was already determined the trading day before. Too much PR can have the reverse affect on investors. When the CEO tries too hard to impress and gather support without showing any signs of profit it does make me doubt big time.
Considering there's not much to look forward to until the grand opening, the slide should continue until January. So, will it go back to .003 is the question now.
Yes, selling is the hardest thing. Our greed kicks in and we hold on too long in many cases. But if we sell too soon and the stock continues to rise...ouch!
It's also on the Stemsoft website.
Yes, nice find.
The stock has made that kind of move in the past. It's very reasonable to see it make that move again. Question is..if it goes over .02..how far up can it climb? And then, how quickly will it retreat? The faster the stock moves up, the more possibility it has for a quick decent too. So, you have to be vigilant and get out after the big move. Then pick it up again after it subsides. But that's easier said than done.
I don't consider that a long just to January. But we all the know the cost of holding a stock too long.
I did initally believe in CBAI when I first bought. I believed in the hype. I just want to see the profits now. Also, I know to make big money you have to make some big moves. This is a gamble for sure. It's like rolling the dice with stocks. You just never know. The hype now is the opening of the new lab. If that goes off without a hitch, then perhaps there's hope.
Personally, I'd rather see the price slowly move up and maintain the ground it has made. Unless the price starts to trend up on a long-term regular basis, there really is no future here.
For sure..in hindsight wouldn't we all like to have looked into our crystal balls and sold at .0109 then picked it up again at .005. If only we could predict the future. It would make it so much easier.
But I think the long holds may get royally screwed here. Those short pump and dumps are nice if you can see it coming.
So far the only people making money are the executive directors..unfortunately, the investors are footing that bill. lol Dilution is death.
No, I would wait a bit longer to see if it slips below .005 again. Then buy. I do expect the price to go back up to 2 cents after the lab opens.
I don't expect that to happen just yet...and I expect to at least make my money back before that time.
I would say I'm more of a gullible man than an intelligent one..and yes, it's the speculation about the industry and the PR from the company. It sounded good. I was looking to invest in a Stem Cell company. I invested in Aatrom (ASTM) which hasn't done well recently and sold off my shares there. I also invested with CBAI and I'm just praying they don't announce in the new year that they will be filing for bankrupcy protection. Because so far they have gone nowhere. Also, if they do a reverse stock split, which I can smell a mile off, then it's not a good sign. Every reverse split I've been through the stock price just keeps going down afterwards. So, instead of thinking the stock price can only go up, don't kid yourselves..it can go to zero.
Wow..this is bad news...at 2007: "Key facts about our company and is quite simple. We feel we are undervalued. We have a stock price of $0.12. We have 22.6 million shares in the float and 54 million shares outstanding, right now fully diluted it's 108 million shares, including warrants and options that are sitting out on the table at this point."
What is it doing now? The dilution is so great..the stock price so damn low. It was a much stronger company 2 years ago.
So things have not gone well indeed.
Thanks locks for that post. Most informative.
I'm still not sold on this company even though I own shares.
That "conference" in front of 3 people was from 2007.
He says: "And that's our focus this year is to actually get to a cash flow positive basis.
As I mentioned in the beginning, we raised $10 million over the last two years, some debt, some equity, and we are looking to potentially take that to the point where we are running of our own cash in just a few months."
They are far far from it. Doesn't provide much confidence. So far a failing company as evidenced by the stock price and balance sheets and last 10-Q stating they may have to cease operations.
Also..one final note..it seems that companies that put out a lot of "PR" news about all their plans and good things and promises for the future tend to be the ones that run aground.
The financials have to speak for themselves, not the CEO trying to pump up business by talking.
Not as an operational Cord Blood company. So that doesn't count. As far as the Cord Blood aspect of the company is concerned, they haven't even begun business. They're only just trying to set up shop after 3 years.
I just have some grave concerns about this company since they have done zero business in 3 years.
Anybody can set up a "company" with a website and start trading shares over the counter behind the guise of a bogus company. I'm not saying that CBAI is bogus, but you can never ever be too sure. There are so so many sharks in the water. You have to be very careful.
Hey, no harm no foul. Thanks for the explanation.
Young Businesses article
If CBAI can be one of the 30% of companies that can survive the first 3 years of operation, it could be a winner. Let's see how many employees they hire over the course of next year. That would be a good sign of growth. I wonder how many employees there are now.
The price is trending down now, so wait.
That gif is hilarious!
Dankbud, do you work for Cord Blood America? You use "us" as you're speaking from the viewpoint of an employee. I noticed a couple other posts using the same pronoun. How many employees of this company are active in the forum here?
I find it rather curious that the whole stem cell industry has been in a nose dive even after the Obama government took over and announced repealing restrictions on Embryonic Stem Cell research. I was really expecting this industry to gather momentum and see charts heading up. But it's not the case as of yet.
I own shares, yes. And I found this forum to see what others were thinking about this stock. I went through this with another OTC stock that promised high rewards..the stock ended up tanking big time and I lost a lot of money. I just hope this one turns out different. I wasn't too happy seeing this stock shoot up to 1.9 then sink back down to half a penny - I wanted to see it stay above a cent. Until the company starts turning a profit, it's all speculation and pump and dumps unfortunately.
Has anyone from this forum, or does anyone know of anyone who has personally visited the facility? I'm just wondering how much of all of this can be trusted. There are so many of these companies that put up a front for business, but there's really no activity going on.
from 10-Q:
"The sale of equity could, depending on the terms of its placement, among other things result in dilution to our shareholders. If our cash flows from operations are significantly less than projected, then we would either need to cut back on our budgeted spending, look to outside sources for additional funding or a combination of the two. If we are unable to access sufficient funds when needed, obtain additional external funding or generate sufficient revenue from the sale of our products and services, we could be forced to curtail or possibly cease operations."
With language like that it hardly puts much confidence in the investor. Already fear of shutting down the operation.
Isn't anyone worried about that?